CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ALVO

AVT29 (proposed aflibercept HD biosimilar)

Phase 3
Alvotech (ALVO)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Jul '27
ALVOPhase 3

AVT29 (proposed aflibercept HD biosimilar) Phase 3 Est. Readout

AVT29 (proposed aflibercept HD biosimilar)
Jul 2027~
CT.gov
00%
Competitive Landscape
Drug Information

Target Indication

Diabetic Macular Edema

Clinical Trial

NCT07489131

Last updated: 8/16/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.